Free Trial
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis

Health Sciences Acquisitions Co. 2 logo
$3.22 +0.12 (+3.87%)
As of 06/24/2025

About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ)

Key Stats

Today's Range
$3.06
$3.24
50-Day Range
$2.42
$3.38
52-Week Range
$9.41
$13.80
Volume
194,614 shs
Average Volume
205,918 shs
Market Capitalization
$36.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Receive HSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter.

HSAQ Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
Quest Completes Acquisition Of Select Laboratory Assets From Allina Health
See More Headlines

HSAQ Stock Analysis - Frequently Asked Questions

Health Sciences Acquisitions Co. 2's stock was trading at $4.00 at the start of the year. Since then, HSAQ stock has decreased by 19.5% and is now trading at $3.22.
View the best growth stocks for 2025 here
.

Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering on Tuesday, August 4th 2020. The company issued 13,900,000 shares at $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Sciences Acquisitions Co. 2 investors own include Churchill Capital Corp IV (CCIV), FS Development (FSDC), Gores Holdings IV (GHIV), Gores Holdings V (GRSVU), Holicity (HOLUU), Kismet Acquisition One (KSMTU) and Lionheart Acquisition Co. II (LCAPU).

Company Calendar

Today
6/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:HSAQ
Web
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$380 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.62) per share
Price / Book
-5.19

Miscellaneous

Free Float
8,757,000
Market Cap
$36.10 million
Optionable
Not Optionable
Beta
0.09
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:HSAQ) was last updated on 6/26/2025 by MarketBeat.com Staff
From Our Partners